Insider Trading & Ownership of STEINMAN LAWRENCE

Location
San Diego, CA
Summary
The estimated value of insider holdings of STEINMAN LAWRENCE is at least $413,984 dollars as of 01 Dec 2025. STEINMAN LAWRENCE is the Director of 180 Life Sciences Corp. and owns shares of 180 Life Sciences Corp. (ATNF) stock worth about $233,617. STEINMAN LAWRENCE is the Director of Pasithea Therapeutics Corp. and owns shares of Pasithea Therapeutics Corp. (KTTA) stock worth about $149,768. STEINMAN LAWRENCE is the Director of BioAtla, Inc. and owns shares of BioAtla, Inc. (BCAB) stock worth about $30,599.
Signature
/s/ Lawrence Steinman
All Insider Reports
All Insider Reports

Notify me when STEINMAN LAWRENCE files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of STEINMAN LAWRENCE

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ATNF, ATNFW 180 Life Sciences Corp. Director $233,617 12 Jul 2025
KTTA, KTTAW Pasithea Therapeutics Corp. Director $149,768 +$100,000 +2% 28 Nov 2025
BCAB BioAtla, Inc. Director $30,599 18 Jun 2025

Insider Transactions Reported by STEINMAN LAWRENCE:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.